The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Non-Executive Chairman

2 Feb 2016 07:00

RNS Number : 7223N
Falanx Group Limited
02 February 2016
 

2 February, 2016

 

FALANX GROUP LIMITED

("Falanx" or "the Company")

 

Falanx Group appoints Mike Read as Non-Executive Chairman

 

Falanx Group Limited, a cyber defence, business intelligence and risk solutions provider working with blue chip and government clients, is pleased to announce the appointment of Mike Read as Non-Executive Chairman. Mr Read will join the Board of Falanx Group with immediate effect.

 

Mike has over 30 years experience in the global Telecommunications, Media and Technology (TMT) sector and has been a director of eight public companies. He has held numerous 'C' level roles in the UK and USA, including, CEO of Pipex Communications, Executive Director at Daisy Group Plc, Non-Executive Director at Nasstar Plc, and Non-Executive Chairman at IntY Ltd. Mike has significant experience helping to build international technology companies, having been involved on over 50 M&A transactions.

 

As announced on 6 November 2015, Karl Barclay, Executive Chairman of Falanx Group, steps down leaving the Board with immediate effect.

 

Mike Read, Non-Executive Chairman of Falanx Group commented:

 

"I am very much looking forward to working with John and the Falanx Group team. This is a vibrant and ambitious company operating in the extremely exciting cyber security industry. Having enjoyed a long and successful career, I recognised a great opportunity to return to pro-active management and assist in the growth of Falanx Group."

 

John Blamire, CEO of Falanx Group commented:

 

"We warmly welcome Mike, who has a very impressive track record in creating shareholder value and successfully leading rapidly developing businesses. I'm delighted to have the opportunity to work alongside such an accomplished business leader. Mike's background fits very well with our growth strategy to develop Falanx Group into one of the UK's leading cyber security companies. His extensive experience in building companies in exciting, emerging sectors will be an invaluable asset in driving our business forward. We also say many thanks to Karl Barclay who has served the Falanx Board tirelessly in his role as Chairman.

 

Save for the information below, there are no further disclosures to be made in accordance with Rule 17, Schedule Two paragraph (g) of the AIM Rules for Companies in respect of the appointment of Mike Read, who is aged 68.

 

Current directorships

Past directorships:

IntY Limited

BNS Mobile Limited

Nasstar PLC

Clevercoms Limited

NZKL Limited

Cloudified Limited

The Secret Footballer

Daisy Group Plc

 

Faultbasic Limited

 

Freedom4 Limited

 

Freedom4 Access Limited

 

MDR Business Solutions Limited

 

Thrive Telecom Limited

 

Xrio Limited

 

Mike Read was a director of Xrio Limited, which entered into a voluntary creditor's liquidation on 10 March 2014. The estimated deficiency as regards members at 10 March 2014 was £247,769.66.

 

Enquiries:

 

Falanx Group Limited

John Blamire, Chief Executive

www.falanxgroup.com

www.falanxassuria.com

+ 44 (0) 20 7856 9457

 

 

 

Panmure Gordon (UK) Limited

Nominated Adviser & Broker

+44 (0) 207 886 2500

Mark Taylor

 

 

 

Redleaf Communications

Charlie Geller

Susie Hudson

+44 (0) 20 7382 4730 

falanx@redleafpr.com 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFMGGZKZGGVZG
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.